Rhino Resource Partners LP Announces Third Quarter 2017 Financial and Operating Results
Nov 08, 2017 12:01 pm UTC| Business
LEXINGTON, Ky., Nov. 08, 2017 -- Rhino Resource Partners LP (OTCQB:RHNO) (“Rhino” or the “Partnership”) announced today its financial and operating results for the quarter ended September 30, 2017. For the quarter, the...
Axsome Therapeutics Reports Third Quarter 2017 Financial Results
Nov 08, 2017 12:01 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported...
The Simply Good Foods Company Reports Fourth Quarter and Full Year Fiscal 2017 Financial Results
Nov 08, 2017 12:01 pm UTC| Business
DENVER, Nov. 08, 2017 -- The Simply Good Foods Company (NASDAQ:SMPL) (NASDAQ:SMPL.W) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today...
MTBC Offers SOAPware Users Free EHR and Practice Management
Nov 08, 2017 12:01 pm UTC| Business
SOMERSET, N.J., Nov. 08, 2017 -- MTBC (NASDAQ:MTBC) (NASDAQ: MTBCP), a leading provider of mHealth and cloud-based clinical and practice management solutions, today announced a special promotion for US physicians who...
Anexinet’s Cloud Leader Ned Bellavance Receives Microsoft® Cloud and Datacenter MVP Award
Nov 08, 2017 12:01 pm UTC| Business
PHILADELPHIA, Nov. 08, 2017 -- Anexinet Corporation, a leading provider of analytics, digital and cloud solutions, today announced that Ned Bellavance, Director of Cloud Solutions, has been honored by Microsoft as a...
Nov 08, 2017 12:01 pm UTC| Business
ALPHARETTA, Ga., Nov. 08, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today reported...
Assembly Biosciences to Present at the Jefferies London Healthcare Conference
Nov 08, 2017 12:01 pm UTC| Business
INDIANAPOLIS, Nov. 08, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...